Skip to main content

Legal & General Group Plc

Position in XERS — Xeris Biopharma Holdings, Inc.

CIK 764068 London, X0

Position in XERS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$15,941,311
+$4,873,237 QoQ
Shares Held
2,012,792
+5.5% QoQ
Ownership
1.10%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#12
of 236 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in XERS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Legal & General Group Plc holds $776,969,626 across 46 Drug Manufacturers - Specialty & Generic names. XERS ranks #8 (2.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 XERS
Xeris Biopharma Holdings, Inc.
This page
2,012,792 $15,941,311

All Filings in XERS

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $15,941,311 2,012,792
2026-03-31 $11,068,074 1,908,289
2025-12-31 $10,960,679 1,396,265
2025-09-30 $11,049,454 1,357,427
2025-06-30 $8,425,627 1,804,203
2025-03-31 $7,749,760 1,411,614
2024-12-31 $781,282 230,467
2024-09-30 $600,902 210,843
2024-06-30 $33,457 14,870
2024-03-31 $32,148 14,547
2023-12-31 $34,185 14,547
2023-09-30 $28,523 15,335
2023-06-30 $43,643 16,658
2023-03-31 $27,015 16,574
2022-12-31 $22,043 16,574
2022-09-30 $25,855 16,574
2022-06-30 $39,320 25,533